Skip to content
healthcare.dev

RYANODEX dantrolene sodium

NDC 42367-540, dantrolene sodium, injection, suspension, from Eagle Pharmaceuticals, Inc..

Product NDC
42367-540
Status
Listed
Labeler
Eagle Pharmaceuticals, Inc.
Dosage form
INJECTION, SUSPENSION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA205579
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42367-540 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DANTROLENE SODIUM250 mg/5mL

Pharmacologic classes

Decreased Striated Muscle Contraction [PE]; Decreased Striated Muscle Tone [PE]; Skeletal Muscle Relaxant [EPC]

Package NDCNDC-11Package
42367-540-32423670540321 VIAL in 1 CARTON (42367-540-32) / 20 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8f7b3ac0-604d-4c78-b545-5e0f8ea3d698

Use it

Look up 42367-540 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42367-540 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42367-540. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.